미국의 욕창 예방 시장 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the united states pressure ulcer prevention market size is expected to increase from USD 2.11 billion in 2025 to USD 2.21 billion in 2026 and reach USD 2.87 billion by 2031, growing at a CAGR of 5.32% over 2026-2031.

This report is Segmented by Product Type (Support Surfaces, Prophylactic Dressings, Positioners & Protectors, Skin Protection Products, Detection & Monitoring Technologies), and End User (Hospitals & ASCs, Clinics, Long Term Care & Urgent Care Centers, Homecare Settings). The Market Forecasts are Provided in Terms of Value (USD).

United States Pressure Ulcer Prevention Market Trends and Insights

Aging, Immobile, and Critically Ill Patient Base

The aging population remains the most durable demand base for the pressure ulcer prevention market because older adults are more likely to experience immobility, frailty, and longer inpatient stays. Baby boomers were in the 61 to 79 age range in 2025, which means the United States continues to carry a large cohort of patients who are more exposed to pressure injury risk across hospitals, long-term care sites, and home settings. That demographic shift matters because prevention spending rises not only with patient numbers, but also with the severity and duration of care required for each high-risk admission. The product mix is also moving upward in value because older patients increasingly present with obesity, cardiovascular conditions, and other comorbidities that require bariatric-rated surfaces and better moisture control. This pattern gives the pressure ulcer prevention market a broader revenue base than simple bed occupancy growth would suggest.

HAPI Cost and Quality-Of-Care Penalties

Hospital-acquired pressure injuries now sit much closer to executive decision making because they affect cost control, care quality, and reputational risk at the same time. The pressure ulcer prevention market benefits from this shift because provider systems are putting more weight on prevention pathways that can be standardized, tracked, and defended during quality review. Cleveland Clinic reported a 36% reduction in hospital-acquired pressure injuries between 2024 and 2025 after implementing a systematic interprofessional prevention protocol, which shows that hospitals are willing to scale structured prevention when the operational case is clear. Documentation standards are also becoming more important because facilities need stronger admission records and clearer proof of prevention activity throughout the patient's stay. That increases the appeal of products and workflows that support early assessment, consistent care delivery, and auditable records across nursing teams.

High Capital and Replacement Cost of Advanced Surfaces

High acquisition and replacement costs continue to limit how quickly the pressure ulcer prevention market can move deeper into smaller hospitals and nursing facilities. Advanced alternating-pressure and low-air-loss systems offer better clinical capability, but they also bring ongoing costs tied to maintenance, replacement covers, pumps, and staff familiarization. Rental models reduce the first purchase hurdle, yet they can also create dependence on third parties and slow standardization across a care network. This gap is most visible in rural hospitals and smaller skilled nursing facilities where prevention budgets compete directly with labor needs and other essential expenses. The result is a two-speed pressure ulcer prevention market in which large health systems upgrade faster while smaller sites stay on older or lower-specification surfaces.

Other drivers and restraints analyzed in the detailed report include:

1. Homecare and Post-Discharge Prevention Demand
2. Better Support Surfaces and Prophylactic Dressings
3. Variable Adherence to Turning and Skin-Assessment Protocols

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Support surfaces captured 62.87% of revenue in 2025, which gave them the largest share within the pressure ulcer prevention market because critical care and perioperative settings still rely on active redistribution as a core prevention measure. This high share reflects the fact that ICU, step-down, and higher-acuity patients often need continuous support that basic surfaces cannot provide consistently. Dynamic systems such as alternating-air, low-air-loss, and lateral rotation platforms continue to command a larger portion of value because they are used for patients with the greatest risk exposure and the highest level of monitoring. Arjo remains well placed in this part of the pressure ulcer prevention market through platforms such as AtmosAir Velaris and Auralis, which support both standard and bariatric care needs across acute settings. Static foam, gel overlays, and hybrid reactive formats remain important in long-term care and home settings where budget discipline is tighter, and product simplicity matters more than full dynamic capability.

Skin protection products are projected to grow at 6.36% CAGR through 2031, which makes them the fastest-growing product category within the pressure ulcer prevention market. That growth reflects wider use of barrier films, no-sting protectants, and preventive skin management in perioperative pathways, ambulatory care, and discharge planning. The pressure ulcer prevention market size for Skin Protection Products is rising because these items are easier to standardize, easier to distribute into non-acute channels, and easier for caregivers to use outside clinical facilities. Prophylactic dressing innovation also supports the category because stronger evidence around friction and shear reduction encourages broader protocol adoption. Detection and Monitoring Technologies remain the smallest segment today, but institutional interest is increasing as providers seek earlier risk visibility and better workflow documentation, and Bruin Biometrics reported that its Provizio SEM Scanner had exceeded 1 million patient scans since commercialization, with an estimated 50,000 reportable pressure injuries prevented.

List of Companies Covered in this Report:

1. Agiliti Health, Inc.
2. AliMed, Inc.
3. Arjo AB
4. Baxter
5. Bruin Biometrics, LLC
6. Cardinal Health
7. Coloplast
8. ConvaTec Group plc
9. DeRoyal Industries
10. EHOB, Inc.
11. Invacare
12. Joerns Healthcare
13. LINET Group
14. Medline Industries
15. Molnlycke Health Care
16. Smith+Nephew plc
17. Solventum Corporation
18. Stryker
19. Talley Group
20. Wellell

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Aging Immobile, and Critically Ill Patient Base
  • 4.2.2 HAPI Cost and Quality-Of-Care Penalties
  • 4.2.3 Homecare and Post-Discharge Prevention Demand
  • 4.2.4 Better Support Surfaces and Prophylactic Dressings
  • 4.2.5 HH-PI eCQM and POA Documentation Pressure
  • 4.2.6 Early Detection Workflows Using SEM and Thermal Imaging
• 4.3 Market Restraints
  • 4.3.1 High Capital and Replacement Cost of Advanced Surfaces
  • 4.3.2 Variable Adherence to Turning and Skin-Assessment Protocols
  • 4.3.3 Device-Related Pressure Injury Complexity
  • 4.3.4 Diagnostic Ambiguity Between POA Injury, Skin Failure, and HAPI
• 4.4 Value / Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Suppliers
  • 4.7.3 Bargaining Power of Buyers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Industry Rivalry

5 Market Size & Growth Forecasts

• 5.1 By Product Type
  • 5.1.1 Support Surfaces
    • 5.1.1.1 Dynamic Support Surfaces
      • 5.1.1.1.1 Alternating-air Mattresses
      • 5.1.1.1.2 Low-air-loss Mattresses
      • 5.1.1.1.3 Air-fluidized and High-air-loss Mattresses
      • 5.1.1.1.4 Lateral Rotation and Microclimate-enabled Surfaces
    • 5.1.1.2 Static Support Surfaces
      • 5.1.1.2.1 Foam Mattresses
      • 5.1.1.2.2 Gel Overlays
      • 5.1.1.2.3 Static Air and Hybrid Reactive Overlays
  • 5.1.2 Prophylactic Dressings
    • 5.1.2.1 Sacral Dressings
    • 5.1.2.2 Heel Dressings
    • 5.1.2.3 Anatomical Multi-site Dressings
  • 5.1.3 Positioners & Protectors
    • 5.1.3.1 Heel Off-loading Boots
    • 5.1.3.2 Turn and Repositioning Aids
    • 5.1.3.3 Wheelchair Cushions and Seat Positioners
  • 5.1.4 Skin Protection Products
    • 5.1.4.1 Barrier Creams
    • 5.1.4.2 No-sting Barrier Films and Skin Protectants
  • 5.1.5 Detection & Monitoring Technologies
    • 5.1.5.1 SEM Scanners
    • 5.1.5.2 Wearable Turn-compliance Sensors
    • 5.1.5.3 Thermal and Imaging-based Assessment Tools
• 5.2 By End User
  • 5.2.1 Hospitals & Ambulatory Surgery Centers
    • 5.2.1.1 Intensive Care Units
    • 5.2.1.2 Medical-Surgical and Step-down Units
    • 5.2.1.3 Perioperative and PACU Settings
  • 5.2.2 Clinics
    • 5.2.2.1 Wound Care Centers
    • 5.2.2.2 Outpatient Specialty Clinics
  • 5.2.3 Long Term Care & Urgent Care Centers
    • 5.2.3.1 Skilled Nursing Facilities
    • 5.2.3.2 Nursing Homes and Assisted Living Facilities
    • 5.2.3.3 Urgent Care Centers
  • 5.2.4 Homecare Settings
    • 5.2.4.1 Home Health Agencies
    • 5.2.4.2 Hospice and Palliative Home Care
    • 5.2.4.3 Caregiver-managed Home Use

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market-level Overview, Core Segments, Financials, Strategic Information, Market Rank/Share, Products & Services, Recent Developments)
  • 6.3.1 Agiliti Health, Inc.
  • 6.3.2 AliMed, Inc.
  • 6.3.3 Arjo AB
  • 6.3.4 Baxter International Inc.
  • 6.3.5 Bruin Biometrics, LLC
  • 6.3.6 Cardinal Health, Inc.
  • 6.3.7 Coloplast Corp.
  • 6.3.8 ConvaTec Group plc
  • 6.3.9 DeRoyal Industries, Inc.
  • 6.3.10 EHOB, Inc.
  • 6.3.11 Invacare Corporation
  • 6.3.12 Joerns Healthcare LLC
  • 6.3.13 LINET Group SE
  • 6.3.14 Medline Industries, LP
  • 6.3.15 Molnlycke Health Care AB
  • 6.3.16 Smith+Nephew plc
  • 6.3.17 Solventum Corporation
  • 6.3.18 Stryker Corporation
  • 6.3.19 Talley Group Limited
  • 6.3.20 Wellell Inc.

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-need Assessment